Condition: Hypogonadism, Male · Sponsor: Halozyme Therapeutics
This is a 52-week open label single arm study + 24-Month long-term safety extension to investigate the effects of XYOSTED, as testosterone replacement therapy, on adolescent males with either primary or secondary hypogonadism. The study aims to determine the effectiveness of XYOSTED measured by continuation or induction of puberty in addition to XYOSTED dosage, safety and testosterone levels.
This description comes directly from the study's public registry record.
Director Clinical Operations, MPH, CPM · 609-331-1670 · jbitsura@halozyme.com
Chief Medical Officer, MD, PhD · 858-344-9400 · ctheuer@halozyme.com
Always discuss trial participation with your own doctor first.
| Children's Hospital Los Angeles | Los Angeles, California, United States | Recruiting |
| Rady Children's Hospital - San Diego | San Diego, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Nemours Children's Specialty Care - Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Massachusetts Memorial Medical Center | Worcester, Massachusetts, United States | Recruiting |
| M Health Fairview U Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Washington University School of Medicine in St. Louis | St Louis, Missouri, United States | Recruiting |
| The DOCS | Las Vegas, Nevada, United States | Recruiting |
| Children's Hospital at Montefiore | The Bronx, New York, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06689085